Provectus Biopharmaceuticals, Inc. (PNK:PVCT) went higher by +9.2715% to close at $ 0.0165. The company exchanged total volume of 0 shares throughout course of last trade however it holds an average trading capacity of 2.92 million shares.
The company is trading below its 50-day moving averages of 0.0489 and down from 200-day moving averages of 0.2063. The firm has price to book ratio of 0.6864 .
The average true range of Provectus Biopharmaceuticals, Inc.’s (PVCT) is recorded at 0.01 and the relative strength index of the stock stands 26.37. The stock price is going above to its 52 week low with 26.92% and lagging behind from its 52 week high with -96.93%. Analyst recommendation for this stock stands at 2.00. A look on the firm performance, its monthly performance is -68.87% and a quarterly performance of -86.53%. The stock price is trading downbeat from its 200 days moving average with -93.83% and down from 50 days moving average with -73.51%.
Centene Corporation (NYSE:CNC) surged +0.05% and closed the trade at $ 57.63. The company recorded a trading capacity of 1.47 million shares below its three months average daily volume of 1.79 million shares. During the last trade, shares reached to high price of $58.12 and touched the low price of $57.45. The stock’s 50-day moving average is noted at $59.57 and its 200-day moving average is stands at $65.53.
Additionally, the company has a PE ratio of 21.23 and has EPS of 2.71. The company has market capitalization of $9.85B.
CNC stock has received ratings from many brokerage firms according to ZACKS. 1 Week Ago, shares have been rated as Buy from 0 brokerage firms and 10 brokerage firms say as Strong Buy. 0 brokerage firms have suggested Sell for the company. 3 brokerage firms have recommended as a Hold. Strong Sell rating was given by 0 brokerage firms. The Company has average brokerage recommendation (ABR) of 1.46 based on consensus of the ZACKS brokerage firms.
Centene Corporation’s (CNC) has price-to-cash ratio of 3.30 and price to sale ratio of 0.28. The company net profit margin is 1.20% A look on the firm performance, its monthly performance is -7.76% and a quarterly performance of -15.61%. The stock price is moving down from its 20 days moving average with -0.08% and isolated negatively from 50 days moving average with -6.24%.